Induction with propofol target-concentration infusion vs. 8% sevoflurane inhalation and alfentanil in hypertensive patients

Citation
N. Nathan et al., Induction with propofol target-concentration infusion vs. 8% sevoflurane inhalation and alfentanil in hypertensive patients, ANAESTHESIA, 56(3), 2001, pp. 251-257
Citations number
31
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Journal title
ANAESTHESIA
ISSN journal
00032409 → ACNP
Volume
56
Issue
3
Year of publication
2001
Pages
251 - 257
Database
ISI
SICI code
0003-2409(200103)56:3<251:IWPTIV>2.0.ZU;2-E
Abstract
Haemodynamic parameters during an inhalation induction with 8% sevoflurane were compared with those obtained with a target-controlled infusion of prop ofol in 50 hypertensive patients in a prospective randomised study. Heart r ate and arterial pressure were recorded continuously. End-tidal sevoflurane and nitrous oxide concentration, SpO2 and bispectral index (BIS) were also collected from the beginning of anaesthesia until 8 min after tracheal int ubation. Patients either received 4 mg.l(-1) target-concentration propofol or performed a vital capacity inhalation of 8% sevoflurane in a high flow o f oxygen (8 l.min(-1)) supplemented with 50% nitrous oxide at loss of consc iousness. As soon as BIS was < 60, 20 <mu>g.kg(-1) alfentanil and 0.6 mg.kg (-1) recuronium were injected and orotracheal intubation was then performed 1 min later. Thereafter, the end-tidal concentration of sevoflurane was re duced to 1.3 minimum alveolar concentration (MAC). Hypotension was defined as a 30% decrease in arterial pressure and was treated with repeated 3-mg b oluses of ephedrine. When 12 mg ephedrine was unable to correct hypotension , the concentration of propofol was reduced by 1 mg.l(-1) and that of sevof lurane by 0.5%. Hypotension occurred in 22 patients in the sevoflurane grou p and 21 in the propofol group, and hypertension occurred in two and three patients in each group, respectively. The maximal reduction in mean (SD) ar terial pressure was similar in the sevoflurane (45 (4) mmHg) and propofol ( 41.3 (2.6) mmHg) groups, as were the ephedrine requirements (9.6 (1.1) vs. 9.1 (1.1) mg, sevoflurane vs. propofol, p > 0.05), the duration of hypotens ion (276 (37) vs. 292 (38) s, sevoflurane vs. propofol, p > 0.05), and the number of hypotensive episodes or anaesthetic changes and depth of anaesthe sia. Nevertheless, heart rate was lower during the 8 min following tracheal intubation in the sevoflurane group. In both groups, the duration of hypot ension was easily controlled either by ephedrine or by adjusting the anaest hetic concentrations. Overall, haemodynamic tolerance appears to be similar in the two techniques. Because hypotension occurred after alfentanil in mo st patients, this study questioned which is the best opioid dose, if any, t o associate with propofol or sevoflurane for the induction in hypertensive patients.